🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase 2a, multi-center, randomized and double-blind placebo-contr...
Status
Completed
Location
CHU Sainte-Justine
Start Date
2022-03-01
Trial ID
NCT04872218
Treatments Being Tested
The purpose of this protocol is to determine the single-dose pharmacokineti...
Status
Completed
Location
California Clinical Trials Medical Group
Start Date
1995-11
Trial ID
NCT00277225
Treatments Being Tested
Pemphigus vulgaris (PV) is a rare, chronic, debilitating, and potentially l...
Status
Unknown
Location
Tongji Hospital
Start Date
2021-02-01
Trial ID
NCT05303272
Treatments Being Tested
Will Abatacept reduce priming of the hair follicle specific T cells and the...
Status
Withdrawn
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT01314495
Treatments Being Tested
The purpose of this study is to assess the efficacy, pharmacokinetics, safe...
Status
Completed
Location
Local Institution
Start Date
2009-12
Trial ID
NCT01001832
Treatments Being Tested
The study hypothesis is that SC abatacept is safe and shows evidence of eff...
Status
Completed
Location
Arthritis Associates of Southern California
Start Date
2014-09
Trial ID
NCT02161406
The purpose of this study is to assess the safety, pharmacokinetics and cli...
Status
Completed
Location
Local Institution
Start Date
1997-03
Trial ID
NCT00287547
Treatments Being Tested
Short Term: The purpose of this clinical research study is to learn if abat...
Status
Completed
Location
Local Institution
Start Date
2002-12
Trial ID
NCT00048568
Treatments Being Tested
The purpose of this study is to compare subcutaneous Abatacept to placebo i...
Status
Completed
Location
Arizona Arthritis & Rheumatology Research PLLC
Start Date
2013-06-17
Trial ID
NCT01860976
The core and extension studies assessed the safety and efficacy of secukinu...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-09
Trial ID
NCT01350804